Revelation Biosciences REVB
NASDAQ REVB
$0.77 -0.03 (-3.75%)
At close: Oct 2, 2026 · 4:00 PM EDT

Revelation Biosciences (REVB) Net Preferred Shares Issued and Repurchased (2021)

Updated

Revelation Biosciences (REVB) posted Net Preferred Shares Issued and Repurchased of $5,000 for FY2022, down 99.9% from $7.4 million in FY2021.

Analysis

Revelation Biosciences (REVB) Net Preferred Shares Issued and Repurchased (2021) Analysis & Trends

  • Business Quant data shows REVB's Net Preferred Shares Issued and Repurchased at $7.4 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Pref. Shares Issued (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Revelation Biosciences 3.01 Mn -46.01 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 7.40 Mn
API Access

Revelation Biosciences Net Preferred Shares Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-preferred-shares-issued-and-repurchased&ticker=REVB&period=max&api_key=YOUR_API_KEY